Taken together, protein ISGylation can promote cancer progression by modulating signaling pathways such as Ki-Ras, EGFR recycling, and Akt in breast cancer and is related to cell proliferation in prostate cancer and PDAC. This evidence concerns the gene KRAS and breast carcinoma.